Effectiveness of Humidified High Flow Nasal Cannula Versus Continuous Nasal Positive Airway Pressure in Managing Respiratory Failure in Preterm Infants: An Emergency Department Study

<b>Background:</b> The HHFNC is routinely utilised as a non-invasive respiratory support for preterm infants with respiratory distress; few studies have compared it to nCPAP for the first treatment of respiratory distress in preterm neonates. This study aims to compare the effectiveness...

Full description

Saved in:
Bibliographic Details
Main Authors: Duaa Yousof Mahboob, Amber Hassan, Faiza Naheed, Arshad Ali Shah, Maria Fareed Siddiqui
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/13/3/602
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850203781514395648
author Duaa Yousof Mahboob
Amber Hassan
Faiza Naheed
Arshad Ali Shah
Maria Fareed Siddiqui
author_facet Duaa Yousof Mahboob
Amber Hassan
Faiza Naheed
Arshad Ali Shah
Maria Fareed Siddiqui
author_sort Duaa Yousof Mahboob
collection DOAJ
description <b>Background:</b> The HHFNC is routinely utilised as a non-invasive respiratory support for preterm infants with respiratory distress; few studies have compared it to nCPAP for the first treatment of respiratory distress in preterm neonates. This study aims to compare the effectiveness and outcomes of HHFNC and nCPAP in improving respiratory outcomes and reducing adverse effects. <b>Methods:</b> The 220 patients from the neonatal unit enrolled in the study (110 in each group) after obtaining written informed consent from their parents/guardians. Nasal CPAP was applied to patients in group A through a nasal mask with the following settings: FiO<sub>2</sub>: 40–60%, PEEP: 5–8 cm H<sub>2</sub>O, flow: 4–6 L/min. HHFNC was initiated at 5 L/min and adjusted between 3–7 L/min based on respiratory status, with FiO<sub>2</sub> starting at 0.4 and modified to maintain SPO<sub>2</sub>; between 88–94%. Study variables were recorded and analysed using SPSS version 23.0. <b>Results:</b> The comparison of nCPAP (Group A) and HHFNC (Group B) showed no significant differences in age, gestational age, or clinical parameters, except for a higher respiratory rate in HHFNC. The HHFNC group had significantly shorter durations of non-invasive ventilator support and hospital stay. Adverse effects were more common in HHFNC, especially nasal mucosal injury, while sepsis was more frequent in nCPAP. Treatment failure occurred more often in the HHFNC group. Neonatal outcomes were similar, with no significant differences in discharge without the need for intubation rates, mortality, or intubation rates. <b>Conclusions:</b> The HHFNC is associated with a shorter duration of non-invasive ventilatory support and hospital stay compared to nCPAP. However, nCPAP demonstrated a significant survival advantage and a lower risk of treatment failure. Both modalities are effective in supporting preterm neonates with respiratory distress, but clinical considerations should guide the choice of therapy. Further research is necessary to confirm these findings and explore strategies to optimize outcomes and mitigate adverse effects associated with each modality.
format Article
id doaj-art-1db7d22685fa44f5961427d38ed7bf38
institution OA Journals
issn 2227-9059
language English
publishDate 2025-03-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj-art-1db7d22685fa44f5961427d38ed7bf382025-08-20T02:11:25ZengMDPI AGBiomedicines2227-90592025-03-0113360210.3390/biomedicines13030602Effectiveness of Humidified High Flow Nasal Cannula Versus Continuous Nasal Positive Airway Pressure in Managing Respiratory Failure in Preterm Infants: An Emergency Department StudyDuaa Yousof Mahboob0Amber Hassan1Faiza Naheed2Arshad Ali Shah3Maria Fareed Siddiqui4Department of Emergency, King Abdulaziz University, Jeddah 21589, Saudi ArabiaEuropean School of Molecular Medicine, University of Milan, 20139 Milan, ItalyFaculty of Pharmacy, University of Lahore, Lahore 54000, PakistanDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Lahore, Lahore 54000, PakistanFaculty of Pharmacy, University of Lahore, Lahore 54000, Pakistan<b>Background:</b> The HHFNC is routinely utilised as a non-invasive respiratory support for preterm infants with respiratory distress; few studies have compared it to nCPAP for the first treatment of respiratory distress in preterm neonates. This study aims to compare the effectiveness and outcomes of HHFNC and nCPAP in improving respiratory outcomes and reducing adverse effects. <b>Methods:</b> The 220 patients from the neonatal unit enrolled in the study (110 in each group) after obtaining written informed consent from their parents/guardians. Nasal CPAP was applied to patients in group A through a nasal mask with the following settings: FiO<sub>2</sub>: 40–60%, PEEP: 5–8 cm H<sub>2</sub>O, flow: 4–6 L/min. HHFNC was initiated at 5 L/min and adjusted between 3–7 L/min based on respiratory status, with FiO<sub>2</sub> starting at 0.4 and modified to maintain SPO<sub>2</sub>; between 88–94%. Study variables were recorded and analysed using SPSS version 23.0. <b>Results:</b> The comparison of nCPAP (Group A) and HHFNC (Group B) showed no significant differences in age, gestational age, or clinical parameters, except for a higher respiratory rate in HHFNC. The HHFNC group had significantly shorter durations of non-invasive ventilator support and hospital stay. Adverse effects were more common in HHFNC, especially nasal mucosal injury, while sepsis was more frequent in nCPAP. Treatment failure occurred more often in the HHFNC group. Neonatal outcomes were similar, with no significant differences in discharge without the need for intubation rates, mortality, or intubation rates. <b>Conclusions:</b> The HHFNC is associated with a shorter duration of non-invasive ventilatory support and hospital stay compared to nCPAP. However, nCPAP demonstrated a significant survival advantage and a lower risk of treatment failure. Both modalities are effective in supporting preterm neonates with respiratory distress, but clinical considerations should guide the choice of therapy. Further research is necessary to confirm these findings and explore strategies to optimize outcomes and mitigate adverse effects associated with each modality.https://www.mdpi.com/2227-9059/13/3/602Continuous Nasal Positive Airway Pressure (nCPAP)Humidified High Flow Nasal (HHFNC)pneumoniarespiratory failure
spellingShingle Duaa Yousof Mahboob
Amber Hassan
Faiza Naheed
Arshad Ali Shah
Maria Fareed Siddiqui
Effectiveness of Humidified High Flow Nasal Cannula Versus Continuous Nasal Positive Airway Pressure in Managing Respiratory Failure in Preterm Infants: An Emergency Department Study
Biomedicines
Continuous Nasal Positive Airway Pressure (nCPAP)
Humidified High Flow Nasal (HHFNC)
pneumonia
respiratory failure
title Effectiveness of Humidified High Flow Nasal Cannula Versus Continuous Nasal Positive Airway Pressure in Managing Respiratory Failure in Preterm Infants: An Emergency Department Study
title_full Effectiveness of Humidified High Flow Nasal Cannula Versus Continuous Nasal Positive Airway Pressure in Managing Respiratory Failure in Preterm Infants: An Emergency Department Study
title_fullStr Effectiveness of Humidified High Flow Nasal Cannula Versus Continuous Nasal Positive Airway Pressure in Managing Respiratory Failure in Preterm Infants: An Emergency Department Study
title_full_unstemmed Effectiveness of Humidified High Flow Nasal Cannula Versus Continuous Nasal Positive Airway Pressure in Managing Respiratory Failure in Preterm Infants: An Emergency Department Study
title_short Effectiveness of Humidified High Flow Nasal Cannula Versus Continuous Nasal Positive Airway Pressure in Managing Respiratory Failure in Preterm Infants: An Emergency Department Study
title_sort effectiveness of humidified high flow nasal cannula versus continuous nasal positive airway pressure in managing respiratory failure in preterm infants an emergency department study
topic Continuous Nasal Positive Airway Pressure (nCPAP)
Humidified High Flow Nasal (HHFNC)
pneumonia
respiratory failure
url https://www.mdpi.com/2227-9059/13/3/602
work_keys_str_mv AT duaayousofmahboob effectivenessofhumidifiedhighflownasalcannulaversuscontinuousnasalpositiveairwaypressureinmanagingrespiratoryfailureinpreterminfantsanemergencydepartmentstudy
AT amberhassan effectivenessofhumidifiedhighflownasalcannulaversuscontinuousnasalpositiveairwaypressureinmanagingrespiratoryfailureinpreterminfantsanemergencydepartmentstudy
AT faizanaheed effectivenessofhumidifiedhighflownasalcannulaversuscontinuousnasalpositiveairwaypressureinmanagingrespiratoryfailureinpreterminfantsanemergencydepartmentstudy
AT arshadalishah effectivenessofhumidifiedhighflownasalcannulaversuscontinuousnasalpositiveairwaypressureinmanagingrespiratoryfailureinpreterminfantsanemergencydepartmentstudy
AT mariafareedsiddiqui effectivenessofhumidifiedhighflownasalcannulaversuscontinuousnasalpositiveairwaypressureinmanagingrespiratoryfailureinpreterminfantsanemergencydepartmentstudy